{"id":"W4417005015","doi":"10.1182/blood-2025-1819","title":"Phase 3 study (inMIND) of tafasitamab plus lenalidomide and rituximab for relapsed or refractory follicular lymphoma: Clinical characteristics and outcomes of patients receiving second-line treatment","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Chemoimmunotherapy; Follicular lymphoma; Refractory (planetary science); Population; Phases of clinical research; Neutropenia; Placebo; Maintenance therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001601432,0.0007315382,0.001615961,0.0002697053,0.000355255,0.0008829596,0.0007114537,0.0005856792,0.002905388],"category_scores_gemma":[0.0009702732,0.0003743576,0.001629426,0.0004291553,0.0004493621,0.0007070202,0.0004375844,0.001494362,0.0005246811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001194107,"about_ca_system_score_gemma":0.001405831,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007419155,"about_ca_topic_score_gemma":0.001669395,"domain_scores_codex":[0.9995319,0.000210208,0.00003127862,0.00008938834,0.00006230517,0.00007488531],"domain_scores_gemma":[0.9992527,0.00008750716,0.0002167195,0.00005517381,0.00007461479,0.000313354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8400854,0.01589735,0.07550074,0.0005639428,0.00307012,0.0002032336,0.000185447,0.001013079,0.01073168,0.0001626921,0.003146408,0.04943998],"study_design_scores_gemma":[0.445312,0.3124995,0.2246904,0.0001107939,0.003368167,0.0007702101,0.0002121098,0.001758482,0.003726651,0.0003133903,0.007174124,0.00006422264],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932042,0.001126234,0.0002666157,0.0001906296,0.00003866687,0.001624128,0.002111468,0.00003253143,0.001405487],"genre_scores_gemma":[0.9902453,0.0004387338,0.0006797127,0.0004664595,0.0001036318,0.001705624,0.005299518,0.00001370062,0.001047234],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002905388,"threshold_uncertainty_score":0.009719551,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03145136658565763,"score_gpt":0.3478430245550208,"score_spread":0.3163916579693632,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}